Achievement of pregnancy three times in the same patient during luteal GnRH agonist administration

Reproductive BioMedicine Online

Volumn 10, Issue 3, 2005, Pages 347-349

  Papanikolaou, Evangelos G ^a   Platteau, Peter ^a   Albano, Carola ^a   Kolibianakis, Efstratios ^a   Devroey, Paul ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

ADHD; Child safety; GnRH agonist; Inadvertent; Spontaneous pregnancy

Indexed keywords

BUSERELIN; BUSERELIN ACETATE; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; DYSLEXIA; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLOW UP; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; LUTEAL PHASE; OVULATION INDUCTION; PARTHENOGENESIS; PREGNANCY; PRENATAL DRUG EXPOSURE; SPONTANEOUS ABORTION; VAGINAL DELIVERY;

EID: 14944345420     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61794-4     Document Type: Article

References (13)

1. Barbaresi W, Katusic S, Colligan R et al. 2004 How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study. Acta Pediatrica Supplement 93, 55-59.
2. Cahill DJ, Fountain SA, Fox R et al. 1994 Outcome of inadvertent administration of a gonadotrophin-releasing hormone agonist (buserelin) in early pregnancy. Human Reproduction. 9, 1243-1246.
3. Colborn T 2004 Neurodevelopment and endocrine disruption. Environmental Health Perspective 112, 944-949.
4. Felberbaum R, Rabe T, Diedrich K 2000 Gonadotropin-releasing hormone: agonists and antagonists. In: Rabe T, Diedrich K, Strowitzki T (eds) Manual on Assisted Reproduction, 2nd updated edition. Springer-Verlag, Heidelberg, pp. 133-164.
5. Kang SK, Choi KC, Cheng KW et al. 2000 Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium. Endocrinology 141, 72-80.
6. Lahat E, Raziel A, Friedler S et al. 1999 Long-term follow-up of children born after inadvertent administration of a gonadotrophin-releasing hormone agonist in early pregnancy. Human Reproduction 14, 2656-2660.
7. Millar R, Lowe S, Conklin D et al. 2001 A novel mammalian receptor for the evolutionarily conserved type II GnRH. Proceedings of the National Academy of Sciences of the USA 98, 9636-9641.
8. Platteau P, Gabbe M, Famelos M et al. 2000a Should we still advise infertile couples to use (barrier) contraception before IVF down-regulation? Fertility and Sterility 74, 655-659.
9. Platteau P, Gabbe M, Talbot M, Healy D 2000b Two consecutive pregnancies during inadvertent gonadotropin-releasing hormone agonist desensitization. Fertility and Sterility 73, 1244-1246.
10. Raga F, Casan EM, Kruessel J et al. 1999 The role of gonadotropin-releasing hormone in murine preimplantation embryonic development. Endocrinology 140, 3705-3712.
11. Shalev RS, Manor O, Kerem B et al. 2001 Developmental dyscalculia is a familial learning disability. Journal of Learning Disability 34, 59-65.
12. Smitz J, Devroey P, Braeckmans P et al. 1987 Management if failed cycles in an IVF/GIFT programme with the combination of a GnRH analog and hMG. Human Reproduction 2, 309-314.
13. Wilshire G, Emmi AM, Gagliari C, Weiss G 1993 Gonadotropin-releasing hormone agonist administration in early human pregnancy is associated with normal outcomes. Fertility and Sterility 60, 980-983.